文献速递外周动脉疾病

氯喹改善缺血肌肉损伤反应并增加HMGB1

Chloroquine improves the response to ischemic muscle injury and increases HMGB1 after arterial ligation.
PubMed 文献 · J Vasc Surg · 2017-03-01

研究评估外周动脉疾病(PAD)肌肉中高迁移率族蛋白B1(HMGB1)的表达,并在小鼠后肢缺血模型中探讨氯喹(CQ)促进HMGB1释放的机制。结果显示PAD患者肌肉HMGB1主要局限于细胞核,CQ可提高小鼠血清和肌肉HMGB1并改善灌注恢复,体外实验提示可能经caspase-1介导途径。

要点

  • PAD患者肌肉HMGB1核表达显著高于对照(P < .05)
  • CQ处理小鼠血清HMGB1升高且肌肉HMGB1染色弥漫(P < .01)
  • CQ组缺血肢体7天灌注比值更高(P < .03),2周脂肪替代更少(P < .03)

核心结论

  • HMGB1在PAD肌肉中显著表达但主要局限于细胞核。
  • CQ可增加HMGB1向肌浆和血清的动员,可能通过caspase-1介导途径。
  • 肌肉可能是PAD中HMGB1的重要额外来源。

研究设计与样本

  • 对接受下肢手术的非PAD疾病、跛行和严重肢体缺血患者行肌肉活检,记录症状和踝肱指数,免疫组化检测HMGB1。
  • 野生型和诱导性HMGB1敲除小鼠行单侧股动脉结扎,野生型小鼠在结扎前后2周腹腔注射CQ。
  • 激光多普勒灌注成像评估灌注恢复,指定时间点测血清和组织HMGB1。
  • 体外培养C2C12成肌细胞,给予递增剂量CQ,检测HMGB1、自噬体形成、p62/SQSTM1积累、caspase-1表达与活性及乳酸脱氢酶。

主要发现

  • 跛行和严重肢体缺血患者HMGB1核表达显著高于对照(P < .05)。
  • CQ处理小鼠血清HMGB1升高、肌肉HMGB1染色弥漫(P < .01)。
  • 野生型小鼠CQ组缺血肢体7天激光多普勒灌注比值更高(P < .03),2周脂肪替代更少(P < .03)。
  • 体外CQ诱导自噬体积累、抑制p62/SQSTM-1降解并激活caspase-1。

临床怎么用

  • 基础研究提示CQ可能通过动员HMGB1促进缺血后肌肉恢复,尚需临床验证。
  • PAD肌肉HMGB1核表达增高可作为机制研究的观察指标。

局限性

  • 研究以小鼠模型和体外细胞实验为主,人体数据仅为肌肉活检表达观察。
  • CQ促进HMGB1释放的具体通路尚未完全明确,临床转化需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We have previously shown that exogenous administration of the nuclear protein high mobility group box 1 (HMGB1) improves angiogenesis after tissue ischemia. Antagonizing HMGB1 prolongs muscle necrosis and deters regeneration. In this study, we evaluated HMGB1 expression in peripheral arterial disease (PAD) and the mechanisms that promote its release in a murine model of hindlimb ischemia. Specifically, we investigated how chloroquine (CQ), a commonly employed disease-modifying antirheumatic drug, promotes HMGB1 release from muscle. We hypothesized that CQ could increase HMGB1 locally and systemically, allowing it to mediate recovery from ischemic injury. METHODS: Muscle biopsies were performed on patients undergoing lower extremity surgery for non-PAD-related disease as well as for claudication and critical limb ischemia. Clinical symptoms and ankle-brachial indices were recorded for each patient. HMGB1 was detected in muscle sections using immunohistochemical staining. Unilateral femoral artery ligation was performed on both wild-type and inducible HMGB1 knockout mice. Wild-type mice were administered intraperitoneal CQ 2 weeks before and after femoral artery ligation. Laser Doppler perfusion imaging was used to determine perfusion recovery. Serum and tissue levels of HMGB1 were measured at designated time points. In vitro, cultured C2C12 myoblasts were treated with increasing doses of CQ. HMGB1, autophagosome formation, p62/SQSTM1 accumulation, caspase-1 expression and activity, and lactate dehydrogenase levels were measured in supernatants and cell lysates. RESULTS: Nuclear expression of HMGB1 was prominent in patients with claudication and critical limb ischemia (P < .05) compared with controls. CQ-treated mice had elevated serum HMGB1 and diffuse HMGB1 staining in muscle (P < .01). In wild-type mice, CQ treatment resulted in higher laser Doppler perfusion imaging ratios in the ischemic limb at 7 days (P < .03) and less fat replacement after 2 weeks (P < .03). In cultured myoblasts, CQ induced autophagosome accumulation, inhibited p62/SQSTM-1 degradation, and activated caspase-1. CONCLUSIONS: HMGB1 is prominently expressed in PAD muscle but mostly confined to the nucleus. Our in vivo data suggest that HMGB1 mobilization into the sarcoplasm and serum can be increased with CQ, possibly through caspase-1-mediated pathways. Whereas HMGB1 can be released by many cell types, these studies suggest that the muscle may be an important additional source that is relevant in PAD.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Xu J, Cui X, Li J, et al. Chloroquine improves the response to ischemic muscle injury and increases HMGB1 after arterial ligation. J Vasc Surg. 2017. PMID: 28259568. doi:10.1016/j.jvs.2017.01.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。